The gray market just got a little less gray in Mississippi
Getting a nursing board, a pharmacy board, and a medical board to agree on lunch is hard enough, so getting all three to sign the same regulatory statement is significant.
That’s what happened in Mississippi this week, when the state’s Board of Nursing, Board of Pharmacy, and State Board of Medical Licensure jointly declared that research-grade peptides are off the table for healthcare providers — not FDA approved, not tested, not safe to compound, prescribe, dispense, or even recommend.
The statement doesn’t leave much wiggle room. Providers can’t delegate the decision to someone else; patients can’t sign it away. And buying ingredients means buying from a source the Mississippi Board of Pharmacy actually licenses — not whichever website ships fastest.
This is the distinction APC has been making for years — just stated with unusual clarity by three regulators at once. Real compounding happens inside a licensed, accountable system.